CRISPR Therapeutics AG (CRSP)
53.73
-1.92
(-3.45%)
USD |
NASDAQ |
Apr 25, 16:00
54.48
+0.75
(+1.40%)
Pre-Market: 08:20
CRISPR Therapeutics Accounts Payable (Quarterly): 38.15M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 38.15M |
September 30, 2023 | 26.15M |
June 30, 2023 | 27.59M |
March 31, 2023 | 45.15M |
December 31, 2022 | 27.43M |
September 30, 2022 | 32.11M |
June 30, 2022 | 25.24M |
March 31, 2022 | 27.11M |
December 31, 2021 | 14.82M |
September 30, 2021 | 10.17M |
June 30, 2021 | 10.14M |
March 31, 2021 | 13.07M |
December 31, 2020 | 9.094M |
September 30, 2020 | 19.02M |
June 30, 2020 | 13.22M |
March 31, 2020 | 11.28M |
Date | Value |
---|---|
December 31, 2019 | 5.944M |
September 30, 2019 | 3.374M |
June 30, 2019 | 7.143M |
March 31, 2019 | 7.131M |
December 31, 2018 | 5.069M |
September 30, 2018 | 5.221M |
June 30, 2018 | 4.479M |
March 31, 2018 | 2.546M |
December 31, 2017 | 1.639M |
September 30, 2017 | 2.116M |
June 30, 2017 | 2.559M |
March 31, 2017 | 3.937M |
December 31, 2016 | 4.569M |
September 30, 2016 | 1.943M |
June 30, 2016 | 3.687M |
December 31, 2015 | 1.584M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.374M
Minimum
Sep 2019
45.15M
Maximum
Mar 2023
19.27M
Average
14.82M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 364.90M |
Intellia Therapeutics Inc | 7.452M |
Novartis AG | 4.062B |
Verve Therapeutics Inc | 6.636M |
AC Immune SA | 1.999M |